JCO Highlighted Lung Cancer Articleshttp://jco.ascopubs.org/American Society of Clinical Oncology (ASCO)http://www.asco.org/images/ascorss.gifJCO Highlighted Lung Cancer Articleshttp://jco.ascopubs.org/<![CDATA[Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non?Small-Cell Lung Cancer]]> <![CDATA[Safety of Bevacizumab in Patients With Non?Small-Cell Lung Cancer and Brain Metastases]]> <![CDATA[Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non?Small-Cell Lung Cancer]]> <![CDATA[Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer]]> <![CDATA[Duration of Chemotherapy for Advanced Non?Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials]]> <![CDATA[Phase II Study of the Anti?Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non?Small-Cell Lung Cancer]]> <![CDATA[Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124]]> <![CDATA[Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non?Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402]]> <![CDATA[Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non?Small-Cell Lung Cancer and Poor Performance Status]]> <![CDATA[Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non?Small-Cell Lung Cancer]]>